In August 2026, Co-Diagnostics, Inc. (the "Company") entered into a material transfer agreement with ReadyGo Diagnostics Ltd ("ReadyGo") to evaluate the potential compatibility of certain ReadyGo sample collection and preparation technologies with the Company’s Co-Dx PCR platform.

 

ReadyGo develops sample collection and preparation technologies designed to simplify the front end of diagnostic testing, including technologies intended to collect biological samples, lyse cells or other biological material, stabilize nucleic acids and prepare samples for downstream molecular analysis. The Company’s Co-Dx PCR platform is being developed to provide real-time PCR testing in decentralized and point-of-care settings through a compact instrument and proprietary test cups.

 

Under the material transfer agreement, ReadyGo has agreed to provide certain of its sampling materials to the Company for feasibility studies, including evaluation and compatibility testing with the Company’s products. The Company believes ReadyGo’s sample collection and preparation technologies may be complementary to the Co-Dx PCR platform and its objective of expanding access to high-quality molecular diagnostics outside traditional laboratory settings. By evaluating technologies designed to simplify the collection, stabilization and preparation of biological samples for molecular analysis, the Company is exploring opportunities to further streamline the sample-to-result workflow and enhance the usability of its Co-Dx PCR platform in decentralized testing environments.

 

The evaluation activities are preliminary in nature, and the material transfer agreement does not obligate either party to enter into any development, supply, commercialization or other commercial arrangement. There can be no assurance that the evaluation activities will result in any additional agreement or commercial relationship between the parties.

 

The Co-Dx PCR platform and associated tests are subject to review by the U.S. Food and Drug Administration and/or other applicable regulatory authorities and are not currently available for sale.